-
FDA Approves Denosumab Biosimiliars for Prior Authorized Indications
13 Mar 2025 17:37 GMT
… , decreased appetite, peripheral edema, headache, dyspnea, anemia, constipation, and diarrhea occurred …
-
Circulating PGC-1α and MOTS-c Peptide as Potential Mitochondrial Biomarkers in Patients Undergoing Aortic Valve Replacement
13 Mar 2025 07:55 GMT
… AVD includes angina, syncope, and dyspnea as late-stage symptoms, which …
-
Modelling Asthma Treatment Dynamics: Insights from the g-Formula
13 Mar 2025 07:55 GMT
… exacerbations and symptoms like bronchospasms, dyspnea, mucus hypersecretion, cough, wheezing, and …
-
Dexamethasone Shows Promise as Cost-Effective Alternative to Tocilizumab for Cytokine Release Syndrome in RRMM
12 Mar 2025 20:24 GMT
… , leading to fever, hypotension, and dyspnea. Tocilizumab and dexamethasone are the …
-
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
12 Mar 2025 12:04 GMT
… , chest pain, paresthesias, headache, and dyspnea, have been received by patients …
-
25.4% of patients with bronchiectasis had symptoms for more than 10 years before diagnosis
11 Mar 2025 19:22 GMT
… : higher modified Medical Research Council dyspnea score (P < .001), older …
-
Apropos Running
11 Mar 2025 16:50 GMT
… mechanisms: grimaces, uncouth form, vomiting, dyspnea… it is a carnival of …
-
Global Ragweed Allergy: Molecular Allergens and Integrated Control Strategies
11 Mar 2025 15:42 GMT
… such as wheezing, coughing, and dyspnea, often characterized by reversible airflow …
-
A Novel Percutaneous Volume Reduction Technique for Giant Emphysematous Bullae: Combined Percutaneous Erythromycin Sclerotherapy With Bronchoscopic Occlusion
11 Mar 2025 07:12 GMT
… confound postoperative outcomes (eg, worsening dyspnea or inflammatory responses). In addition … , which is associated with reduced dyspnea and enhanced functional capacity in … GEB patients, with improvements in dyspnea, pulmonary function, and quality of …
-
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
11 Mar 2025 03:35 GMT
… respiratory tract infection, encephalopathy, edema, dyspnea and viral infections.
Please see …